SCHEMBL13697482

SCHEMBL13697482

CC(=O)OCc1ccc2[nH]c3ccccc3c2c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.55
KDM4E B2RXH2 7/20 0.55
MAPT P10636 5/20 0.55
KMT2A Q03164 4/20 0.55
MEN1 O00255 3/20 0.55
SMN1; SMN2 Q16637 3/20 0.55
HCRTR1 O43613 1/20 0.55
RAB9A P51151 1/20 0.55
MTNR1A P48039 1/20 0.51
MTNR1B P49286 1/20 0.51
HPGD P15428 2/20 0.47
HSD17B10 Q99714 2/20 0.47
GAA P10253 1/20 0.47
GABRP O00591 2/20 0.47
GABRD O14764 2/20 0.47
GABRA1 P14867 2/20 0.47
GABRB1 P18505 2/20 0.47
GABRG2 P18507 2/20 0.47
GABRB3 P28472 2/20 0.47
GABRA5 P31644 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27540731 0.80 KDM4E (0.57) ALDH1A1KDM4EMAPTKMT2AMEN1
SCHEMBL11960244 0.79 PARP14 (0.45) ALDH1A1KDM4EMAPTKMT2AMEN1
SCHEMBL6222215 0.78 ALDH1A1 (0.62) ALDH1A1KDM4EMAPTKMT2ASMN1; SMN2
SCHEMBL9723008 0.78 KDM4E (0.53) ALDH1A1KDM4EMAPTKMT2AMEN1
Carbazole SCHEMBL27468925 0.78 KDM4E (0.63) ALDH1A1KDM4EMAPTKMT2AMEN1
SCHEMBL13697649 0.77 KDM4E (0.55) ALDH1A1KDM4EMAPTKMT2AMEN1
SCHEMBL6615916 0.76 KDM4E (0.54) ALDH1A1KDM4EMAPTKMT2AMEN1
SCHEMBL20273176 0.76 KDM4E (0.45) ALDH1A1KDM4EMAPTKMT2AMEN1
SCHEMBL31324185 0.75 KDM4E (0.83) ALDH1A1KDM4EMAPTKMT2AMEN1
SCHEMBL18938363 0.75 KDM4E (0.83) ALDH1A1KDM4EMAPTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8772311-B2 Harmine derivatives, intermediates used in their preparations, preparation processes and use thereof XINJIANG HUASHIDAN PHARMACEUTICAL RESEARCH CO., LTD. (CN) 2014-07-08 US disclosed
US-8772311-B2 Harmine derivatives, intermediates used in their preparations, preparation processes and use thereof XINJIANG HUASHIDAN PHARMACEUTICAL RESEARCH CO., LTD. (CN) 2014-07-08 US disclosed
US-20090227619-A1 Harmine derivatives, intermediates used in their preparations, preparation processes and use therefo XINJIANG HUASHIDAN PHARMACEUTICAL RESEARCH CO., LTD. (CN) 2009-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227619-A1 Harmine derivatives, intermediates used in their preparations, preparation processes and use therefo TPH1, HTR1F, TPH2 ALDH1A1 324/4885KDM4E 2869/4885MAPT 1483/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.